SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-053554
Filing Date
2024-05-06
Accepted
2024-05-06 16:10:42
Documents
80
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q fgen-20240331.htm   iXBRL 10-Q 2524611
2 EX-10.1 fgen-ex10_1.htm EX-10.1 25927
3 EX-10.2 fgen-ex10_2.htm EX-10.2 191582
4 EX-10.3 fgen-ex10_3.htm EX-10.3 33355
5 EX-10.4 fgen-ex10_4.htm EX-10.4 292197
6 EX-31.1 fgen-ex31_1.htm EX-31.1 9270
7 EX-31.2 fgen-ex31_2.htm EX-31.2 9258
8 EX-32.1 fgen-ex32_1.htm EX-32.1 8660
9 GRAPHIC img88376381_0.jpg GRAPHIC 5061
  Complete submission text file 0000950170-24-053554.txt   11134093

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT fgen-20240331.xsd EX-101.SCH 1751130
83 EXTRACTED XBRL INSTANCE DOCUMENT fgen-20240331_htm.xml XML 1735477
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36740 | Film No.: 24917587
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)